03:43 PM EST - Aeterna Zentaris Inc. : announced that it has been awarded a $1.5-million grant from the German Ministry of Education and Research to develop, up to the clinical stage, cytotoxic conjugates of the proprietary cytotoxic compound disorazol Z and peptides targeting G-protein coupled receptors, including the LHRH receptors. Aeterna Zentaris Inc.
shares T.AEZ are trading up $0.02 at $1.76.
